Many hospitals procure patented immunotherapy drugs through bulk contracts with multinational pharmaceutical companies; contracts that explicitly prohibit disclosure of negotiated prices to third parties. Submitting purchase invoices to the CGHS, hospitals warn, could expose them to breach of contract claims, and the drugmakers can initiate legal proceedings or stop the supply of these medicines.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/kU7MgZP
May 13, 2026
May 11, 2026
Apollo Hospitals launches super speciality centre in Dadar to expand advanced care access in Mumbai
Centre to offer super-speciality services across cardiology, neurology, oncology, gastroenterology, orthopaedics, transplantation and pulmonology with diagnostics, robotics-enabled care and 24x7 clinical access
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/cdXzegP
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/cdXzegP
AIIMS Launches Low-Cost Advanced Test to Make Epilepsy Treatment Safer
The new facility at AIIMS' Neurosciences Centre will monitor the levels of two commonly used anti-epilepsy medicines — levetiracetam and lamotrigine — in a patient's blood. Doctors say this is important because the same dose may affect patients differently, and incorrect drug levels can either fail to control seizures or cause toxicity.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/TdyVeI5
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/TdyVeI5
Subscribe to:
Posts (Atom)